BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16971699)

  • 41. Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.
    Yadak R; Sillevis Smitt P; van Gisbergen MW; van Til NP; de Coo IF
    Front Cell Neurosci; 2017; 11():31. PubMed ID: 28261062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) in two Mexican brothers harboring a novel mutation in the ECGF1 gene.
    Monroy N; Macías Kauffer LR; Mutchinick OM
    Eur J Med Genet; 2008; 51(3):245-50. PubMed ID: 18280229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thymidine phosphorylase gene mutation is not a primary cause of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).
    Kumagai Y; Sugiura Y; Sugeno H; Takebayashi Y; Takenoshita S; Yamamoto T
    Intern Med; 2006; 45(7):443-6. PubMed ID: 16679698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel thymidine phosphorylase mutation in a Spanish MNGIE patient.
    Gamez J; Lara MC; Mearin F; Oliveras-Ley C; Raguer N; Olive M; Leist AT; Perello A; Perona M; Cervera C; Andreu AL; Martí R; Hirano M
    J Neurol Sci; 2005 Jan; 228(1):35-9. PubMed ID: 15607208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha-1-Antitrypsin Promoter Improves the Efficacy of an Adeno-Associated Virus Vector for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy.
    Cabrera-Pérez R; Vila-Julià F; Hirano M; Mingozzi F; Torres-Torronteras J; Martí R
    Hum Gene Ther; 2019 Aug; 30(8):985-998. PubMed ID: 30900470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications.
    D'Angelo R; Boschetti E; Amore G; Costa R; Pugliese A; Caporali L; Gramegna LL; Papa V; Vizioli L; Capristo M; Contin M; Mohamed S; Cenacchi G; Lodi R; Morelli MC; Fasano L; Pisani L; Cescon M; Tonon C; Pinna AD; Dotti MT; Sicurelli F; Scarpelli M; Filosto M; Casali C; Pironi L; Carelli V; De Giorgio R; Rinaldi R
    J Neurol; 2020 Dec; 267(12):3702-3710. PubMed ID: 32683607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy.
    Halter JP; Michael W; Schüpbach M; Mandel H; Casali C; Orchard K; Collin M; Valcarcel D; Rovelli A; Filosto M; Dotti MT; Marotta G; Pintos G; Barba P; Accarino A; Ferra C; Illa I; Beguin Y; Bakker JA; Boelens JJ; de Coo IF; Fay K; Sue CM; Nachbaur D; Zoller H; Sobreira C; Pinto Simoes B; Hammans SR; Savage D; Martí R; Chinnery PF; Elhasid R; Gratwohl A; Hirano M
    Brain; 2015 Oct; 138(Pt 10):2847-58. PubMed ID: 26264513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitochondrial neurogastrointestinal encephalomyopathy.
    Borhani Haghighi A; Nabavizadeh A; Sass JO; Safari A; Lankarani KB
    Arch Iran Med; 2009 Nov; 12(6):588-90. PubMed ID: 19877753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy.
    Levene M; Bain MD; Moran NF; Nirmalananthan N; Poulton J; Scarpelli M; Filosto M; Mandel H; MacKinnon AD; Fairbanks L; Pacitti D; Bax BE
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30959750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic intestinal pseudo-obstruction and neurological manifestations in early adulthood: considering MNGIE syndrome in differential diagnosis.
    Oztas E; Ozin Y; Onder F; Onal IK; Oguz D; Kocaefe C
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):195-7. PubMed ID: 20593055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical toxicity evaluation of erythrocyte-encapsulated thymidine phosphorylase in BALB/c mice and beagle dogs: an enzyme-replacement therapy for mitochondrial neurogastrointestinal encephalomyopathy.
    Levene M; Coleman DG; Kilpatrick HC; Fairbanks LD; Gangadharan B; Gasson C; Bax BE
    Toxicol Sci; 2013 Jan; 131(1):311-24. PubMed ID: 22977166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery profiling and bioinformatics analysis of serum microRNA in Mitochondrial NeuroGastroIntestinal Encephalomyopathy (MNGIE).
    Levene M; Enguita FJ; Bax BE
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(11):618-629. PubMed ID: 30587073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy.
    Nishigaki Y; Marti R; Hirano M
    Hum Mol Genet; 2004 Jan; 13(1):91-101. PubMed ID: 14613972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy.
    Boschetti E; D'Alessandro R; Bianco F; Carelli V; Cenacchi G; Pinna AD; Del Gaudio M; Rinaldi R; Stanghellini V; Pironi L; Rhoden K; Tugnoli V; Casali C; De Giorgio R
    PLoS One; 2014; 9(5):e96692. PubMed ID: 24802030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thymidine phosphorylase is both a therapeutic and a suicide gene in a murine model of mitochondrial neurogastrointestinal encephalomyopathy.
    López-Estévez S; Ferrer G; Torres-Torronteras J; Mansilla MJ; Casacuberta-Serra S; Martorell L; Hirano M; Martí R; Barquinero J
    Gene Ther; 2014 Jul; 21(7):673-81. PubMed ID: 24807807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Compound heterozygous mutations of TYMP as underlying causes of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).
    Suh BC; Jeong HN; Yoon BS; Park JH; Kim HJ; Park SW; Hwang JH; Choi BO; Chung KW
    Mol Med Rep; 2013 Jul; 8(1):17-22. PubMed ID: 23685548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thymidine phosphorylase gene mutations cause mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).
    Hirano M; Nishino I; Nishigaki Y; Martí R
    Intern Med; 2006; 45(19):1103. PubMed ID: 17077575
    [No Abstract]   [Full Text] [Related]  

  • 58. MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation.
    Szigeti K; Wong LJ; Perng CL; Saifi GM; Eldin K; Adesina AM; Cass DL; Hirano M; Lupski JR; Scaglia F
    J Med Genet; 2004 Feb; 41(2):125-9. PubMed ID: 14757860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of thymidine phosphorylase activity in human blood cells and fibroblasts by a nonradiochemical assay using reversed-phase high-performance liquid chromatography.
    van Kuilenburg AB; Zoetekouw L
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1261-4. PubMed ID: 17065103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MNGIE: from nuclear DNA to mitochondrial DNA.
    Nishino I; Spinazzola A; Hirano M
    Neuromuscul Disord; 2001 Jan; 11(1):7-10. PubMed ID: 11166160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.